Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
04/16 04:29
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
03/14 05:40
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
02/16 05:28
Mineralys Therapeutics | 4:持股变动声明-高管 Levy Adam Scott
02/16 05:28
Mineralys Therapeutics | 4:持股变动声明-高管 Congleton Jon
02/16 05:28
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等
02/16 05:23
Mineralys Therapeutics | 4:持股变动声明-董事 AKKARAJU SRINIVAS
02/15 10:08
Mineralys Therapeutics | 4:持股变动声明-股东 Samsara BioCapital GP, LLC
02/15 10:08
Mineralys Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
02/15 08:53
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%)等
02/14 19:07
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-Catalys Pacific Fund, LP(22.4%),Catalys Pacific Fund GP, LP(22.4%)等
02/14 05:21
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
02/14 05:12
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-HBM Healthcare Investments (Cayman) Ltd.(5.5%)
02/14 05:11
Mineralys Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
02/13 05:53
Mineralys Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Samsara BioCapital, L.P.(10.3%),Samsara BioCapital GP, LLC(10.3%)等
02/13 05:51
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
01/12 13:00
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
2023/12/13 06:08
Mineralys Therapeutics | 4:持股变动声明-首席执行官 Congleton Jon
2023/11/28 05:01
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
2023/11/15 07:18
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
2023/11/08 06:15
暂无数据
暂无数据